Jonathan Gewirtz, MD
Gynecology · Mays Landing, NJNPI 1639155542
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 58.2% of the total. Reporting peaked in 2019 at $480 and has fallen 93.3% since, to $32 in 2025.
Across 35 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$430
- Daiichi Sankyo Inc.$130
- Lupin Inc.$57
- Covidien LP$49
- Braeburn Inc.$32
- Bayer$15
- plus $25 from 2 others
What the payments were for
- Food & beverage$72498%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $430 |
| Daiichi Sankyo Inc. | 9 | $130 |
| Lupin Inc. | 3 | $57 |
| Covidien LP | 2 | $49 |
| Braeburn Inc. | 2 | $32 |
| Bayer | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$219
How this compares
$738 in reported general payments places this provider in the 60th percentile of 97 gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $28,545 |
| EliquisApixaban | 34 | $19,043 |
| MyrbetriqMirabegron | 18 | $9,043 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $5,102 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,715 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $1,450 |
| Rosuvastatin Calcium | 24 | $1,236 |
| Levemir FlexpenInsulin Detemir | 11 | $1,074 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $877 |
| Atorvastatin Calcium | 93 | $710 |
| Pregabalin | 21 | $616 |
| Olmesartan Medoxomil | 15 | $557 |
| Metformin Hcl | 77 | $497 |
| Fluticasone Propionate | 40 | $448 |
| Hydralazine Hcl | 21 | $401 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Mays Landing
- Ronald PortadinMays Landing$602
- James TursiLumberton$217K
- Marco PelosiBayonne$164K
- Heather van RaaltePrinceton$140K
- Scott EderPrinceton$124K
- Michael VardyEnglewood$114K
- Daryl BoffardUnion$55K
- Shyama MathewsPlainsboro$54K
- Lora LiuJersey City$36K
- Mark EinsteinNewark$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.